Short answer
Lucid Diagnostics Inc. (LUCD) filed its Q1 2026 10-Q quarterly report on May 13, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1M (up 51.7% year over year) with net income of −$14M.
Q1 2026 key financials · XBRL
- Revenue
- $1M
- +51.7% YoY
- Net income
- −$14M
- +48.3% YoY
- Operating margin
- -964.5%
- EPS (diluted)
- −$0.17
- +67.3% YoY
Source: XBRL data from the Lucid Diagnostics Inc. (LUCD) Q1 2026 10-Q on SEC EDGAR. USD.
Lucid Diagnostics Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1.3M, up $0.5M YoY from $0.8M, driven by EsoGuard test consideration
- Cost of revenue $1.6M vs $1.6M YoY; gross margin negative 23.1% vs negative 100.0%
- Sales and marketing expenses $5.0M vs $4.1M; general and administrative expenses $5.4M vs $6.2M
- Cash $27.9M at March 31; operating cash use $12.1M and financing cash inflow $5.5M
- April offering net proceeds $16.8M; recurring losses, negative operating cash flow, and reimbursement uncertainty remain headwinds
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lucid Diagnostics Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.